Rick Simpson Oil (RSO) in Vermont: The Complete Guide by OilWell Cannabis

Vermont changed everything when it became the first state to legalize cannabis through legislative action rather than a ballot initiative. That 2020 milestone—Act 164—didn’t just make Vermont the ninth state to embrace adult-use cannabis; it created a laboratory for what thoughtful, health-conscious cannabis access could look like in a rural, community-oriented state. But here in the Green Mountains, we’ve watched something frustrating unfold: even with legalization, the RSO that cancer patients and chronic pain sufferers desperately need remains expensive, inconsistently available, and often poorly explained.

That’s why we’re reaching out to Vermont directly. We see what’s happening in Burlington’s few dispensaries, in the waiting rooms at UVM Medical Center, in the veteran support groups in White River Junction, and in the living rooms of aging Vermonters from Stowe to Brattleboro who’ve been let down by conventional medicine. We see it because we lived it ourselves—not in Vermont, but in the Borderplex between Texas and Mexico, where desperation and pharmaceutical failures taught us what real medicine looks like.

This guide is for the Vermont cancer patient researching at 2 AM after a long day at the cancer center. For the veteran in Rutland trying to taper off benzos. For the farmer in the Northeast Kingdom dealing with chronic back pain. For the caregiver in Bennington looking for something—anything—that might help their loved one sleep through the night. We’re not here to sell you hope. We’re here to give you the most complete, honest, Vermont-adapted RSO education that exists anywhere, backed by the same peer-reviewed research Vermont’s medical community relies on, and anchored by formulas we publish openly because that’s what Rick Simpson would have wanted.

About Rick Simpson and Traditional RSO: What Vermonters Need to Know

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia—just across the border from Maine, a region that shares more with Vermont’s rural character and small-town medical challenges than you might think. He wasn’t a doctor, scientist, or medical professional. He was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. He reported that the medications he was prescribed either failed to help or made his condition worse. Cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe it, the request was refused.

Vermont parallel: We know many Vermonters have experienced this exact scenario—whether it’s a workplace injury on a construction site in Burlington, a farming accident in the Champlain Valley, or a head injury from a ski fall in Stowe. The experience of being told “no” by a doctor when you know something works resonates deeply here, where community-based healing traditions often run parallel to (and sometimes ahead of) institutional medicine.

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC reportedly slowed tumors in mice. That study—never replicated in humans—became his foundational reference point .

The pivotal moment came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Rather than conventional treatment, Simpson applied concentrated cannabis oil to the lesions, covered them with bandages, and claimed they disappeared within four days. No independent medical verification, biopsy confirmation, or clinical follow-up has ever been published in a peer-reviewed source .

Important context for Vermont readers: This is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as proof of cancer cure. However, they are historically significant as the catalyst for a global movement that eventually reached Vermont’s dispensaries and online forums.

The crusade—spreading the oil

After 2003, Simpson committed to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others, charging nothing. By his account, he helped dozens with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia—the same conditions that drive Vermonters to search for alternatives when the healthcare system in Montpelier or the specialists at Dartmouth-Hitchcock have no more options .

His story reached global audiences through the 2005 documentary Run From The Cure, which became foundational in cannabis advocacy. In Vermont’s tight-knit communities—whether it’s a cancer support group in Middlebury or a veteran’s circle in Springfield—word-of-mouth spreads fast. This documentary was how many Vermonters first learned about concentrated cannabis oil as medicine.

Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. He eventually left Canada for Europe, living in Croatia and the Netherlands .

Vermont criminal justice connection: While Vermont has been progressive on cannabis—decriminalizing in 2013, medical in 2004, and adult-use in 2020—many Vermonters still carry the weight of past cannabis convictions. The state’s expungement process, while available, is complex. Simpson’s story of legal persecution resonates with anyone in Vermont who remembers when cannabis meant criminalization, not entrepreneurship.

In 2012, he published Phoenix Tears and maintained phoenixtears.ca .

Throughout his career, Simpson maintained that cannabis oil could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as a fight against institutional corruption .

Important context for Vermont: This conspiratorial framing reflects a worldview shared by many in early cannabis advocacy and still present in Vermont’s alternative medicine circles. The goal here is to present what Simpson believed while directing you toward evidence-based understanding—the same standard Vermont’s medical community applies to any treatment.

The traditional RSO protocol—Simpson’s 60-gram, 90-day regimen

Simpson’s core recommendation was a structured oral protocol: consume 60 grams of concentrated cannabis oil over approximately 90 days. This is the protocol that Vermonters searching “RSO dosing Vermont” or “how to take RSO” will encounter online. Here’s exactly what it entails:

Goal

Consume 60 grams of high-THC cannabis oil over ~90 days. Simpson considered this the minimum for serious cancer treatment.

Titration schedule

• Week 1: Dose the size of half a grain of rice (~10-15mg oil) three times daily. Total: 30-45mg/day.
• Weeks 2-5: Double every four days, aiming for ~1 gram/day by week 5-6, divided into three doses.
• Weeks 5-12: Maintain 1 gram/day (333mg per dose) until 60 grams consumed.
• Post-protocol: 1-2 grams/month for maintenance.

Administration methods

• Oral: Primary method—sublingual or swallowed for systemic absorption.
• Topical: Direct application for skin lesions, combined with oral dosing.
• Inhalation: Not primary—use for immediate symptom relief only.

Tolerance and psychoactive effects

Simpson claimed patients develop THC tolerance in 3-4 weeks. He recommended nighttime dosing initially and warned against driving.

Important context for evaluating this protocol

This is critical for Vermont readers to understand:

• No controlled trial validation. No randomized controlled trials, cohort studies, or well-documented case series exist for this protocol.
• Crude, unstandardized material. Every batch varied. Traditional RSO potency was unknown and inconsistent—unlike OilWell’s lab-verified formulas.
• Very high THC exposure. At peak dosing (1 gram/day of 60-90% THC oil), patients consumed 600-900mg delta-9 THC daily—far exceeding anything studied clinically. FDA-approved dronabinol is typically 2.5-20mg/day.
• Real risks. At those doses: severe intoxication, anxiety, panic, tachycardia, hypotension, cannabis use disorder [1][13][14][15].
• Vermont oncology context: Patients with active cancer are medically complex. Using unregulated cannabis oil as primary treatment—potentially replacing proven therapies—introduces harm that extends beyond the oil itself.

What traditional RSO was as a product

Source material

Single high-THC indica strains, no standardization. Availability depended on growing season—something any Vermont gardener understands intimately.

Extraction solvent

Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol—neither food-grade. This is a major safety issue, especially for Vermont’s health-conscious consumers.

Extraction process

1. Cannabis in bucket + solvent → agitate → filter through cheesecloth
2. Repeat wash → combine liquids → rice cooker evaporation
3. Thick dark oil remains → transfer to syringes

The rice cooker method maintained temperatures that evaporated solvent but also decarboxylated THCa and destroyed terpenes.

Appearance

Nearly black, thick, tar-like, sticky, with possible solvent-residual smell. Traditional RSO looked nothing like OilWell’s MCT-oil formulation.

Cannabinoid profile

• Fully decarboxylated, THC-dominant (60-90% estimated)
• Minor cannabinoids at natural, uncontrolled ratios
• No lab verification

Terpene content

Minimal to none. The solvent + heat process volatilized terpenes at temperatures well below cannabinoid degradation. Vermont’s cannabis enthusiasts—used to terpene-rich flower from local cultivators—should understand that traditional RSO was effectively terpene-free.

Standardization and testing

None. Every batch differed. No COA, no contaminant screening. Vermont’s legal market now requires testing, but traditional RSO predates that infrastructure.

Residual solvent risk

Naphtha may contain benzene, toluene, other carcinogens. Incomplete purging is hard to verify without lab testing. Modern extraction uses food-grade ethanol or CO₂—something Vermont’s eco-conscious consumers appreciate.

Simpson’s claims vs. the evidence record

Simpson claimed RSO could cure cancer and many diseases. Let’s evaluate this honestly, using the same standards Vermont’s medical community applies.

What Simpson was not

He wasn’t a scientist, physician, or researcher. He never designed, conducted, or published a clinical trial. His evidence was personal experience and testimonials—no controls, no verification, no blinding.

What preclinical literature shows

• In vitro: THC and CBD can induce apoptosis, inhibit proliferation, reduce angiogenesis in cancer cell lines .
• Animal models: Some tumor growth inhibition in mice/rats .

What preclinical literature does NOT show

• No translation to proven human cancer cures.
• No human clinical trial demonstrating RSO cures cancer.
• Small human trials (especially glioblastoma) are exploratory, not curative .

Institutional positions

• NCI: Acknowledges anticancer research but does not endorse cannabis as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD) for seizures and synthetic THC for chemo nausea/AIDS wasting [1].
• Health Canada: Never approved RSO as cancer cure.
• NCCIH: Strongest evidence is for epilepsies, chemo nausea, HIV/AIDS appetite—not cancer cure [1].

What Simpson got right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create the conditions for today’s legal cannabis industry and research infrastructure—including what’s now available in Vermont.

What he overstated

The leap from preclinical signals to cancer cure wasn’t supported then and isn’t now. Encouraging patients to rely on RSO instead of proven therapies carries genuine harm potential. Delayed treatment for treatable cancers is documented in alternative medicine literature. Vermont readers: If you’re considering RSO as part of cancer care, consult your oncologist at UVM Medical Center or Dartmouth-Hitchcock. RSO should complement, not replace, proven treatments.

The legacy of Rick Simpson and modern RSO

The term “RSO” is now generic. Many products labeled RSO bear little resemblance to Simpson’s original. In Vermont dispensaries, you’ll see “RSO” on syringes that may have completely different extraction methods, cannabinoid profiles, and quality standards.

Simpson was critical of commercial products departing from his method. His model was anti-commercial—he gave oil away free and urged DIY production. The modern industry commercialized what he distributed freely. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) divides the cannabis community.

What matters for Vermonters: modern RSO has evolved substantially, and those changes are directly relevant to what you’re buying in Burlington, Montpelier, or ordering online to your doorstep in St. Johnsbury.

Traditional RSO vs. modern formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Food-grade ethanol/CO₂ (solvent-free blending)
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not performed	Full panel (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual solvents	Significant risk	Controlled and tested—none in final product
Dosing precision	Approximate syringe-based	Measured per mL (553 mg/mL) with graduated dropper
Product formats	Single thick oil only	Sublingual oil + vape cartridge
THCa preservation	No—fully decarboxylated	Yes—1,500 mg THCa as separate ingredient
Evidence approach	Anecdotal testimony	Research-backed, evidence-weighted

Why OilWell’s formulas diverge from traditional RSO

Multi-cannabinoid approach

Traditional RSO relied on whatever single strain was available. Vermont’s cannabis cultivators know that single-strain medicine is limiting—like trying to treat every medical condition with only one pharmaceutical. OilWell’s formulas intentionally include seven cannabinoids (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) because entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

Terpene preservation and addition

Traditional RSO had essentially no terpenes due to solvent and heat destruction. Vermont’s craft cannabis community values terpenes—we know they matter for aroma, flavor, and effect. OilWell includes live terpenes at 5% with a specific seven-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) because terpene bioactivity is plausible and supported at preclinical levels [20]-[28].

THCa as separate ingredient

Traditional RSO fully decarboxylated everything. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct, non-psychoactive compound—preserving potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism that heating destroys [12].

Reduced delta-9 THC dominance

Traditional RSO was 60-90% delta-9 THC. OilWell uses only 90 mg delta-9 THC while incorporating 6,000 mg delta-8 THC and distributing remaining content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects broader cannabinoid research rather than single-compound dominance.

Product format innovation

Simpson envisioned only oral syringe oil. OilWell offers both 30 mL sublingual oil and 1-gram vape cartridge, acknowledging different delivery routes have different pharmacokinetic profiles—crucial for Vermont patients needing both sustained relief and fast-acting options [14].

Solvent safety and extraction evolution

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha contains benzene, toluene, other carcinogens. Vermont’s environmental consciousness makes this especially concerning.

Modern extraction uses food-grade ethanol or supercritical CO₂ with validated analytical testing. OilWell’s approach is even cleaner: we don’t extract at all. We formulate from individual cannabinoid distillates and isolates, blending them in controlled environment. No solvents in finished product.

We use organic MCT oil as carrier—food-grade, facilitates sublingual absorption, neutral taste. This is a significant improvement over tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. COAs are available on request and through our website—something Vermont’s discerning consumers should demand from any product.

The decarboxylation question

Traditional RSO was fully decarboxylated—heat converted all THCa to THC, destroying the acidic precursor.

OilWell’s sublingual formula preserves THCa at 1,500 mg. This creates three usage options:

Option 1—Raw, no heat: All 1,500 mg stays as THCa—completely non-psychoactive. Compatible with work, driving, daytime use. No impairment whatsoever.

Option 2—Fully activated, home decarboxylation: Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass. Converts 1,500 mg THCa → ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC = ~1,405 mg total delta-9 THC. Achieves psychoactive potency comparable to traditional illegal RSO, 100% legally, at your discretion.

Option 3—Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset available—1-2 minutes.

Conversion chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (loss of CO₂ molecule).

This puts potency decision entirely in your hands—aligning with Simpson’s principle that patients control their medicine, but implementing it through actual chemistry.

Terpene loss in traditional RSO

Terpenes volatilize at 21-157°C. Traditional RSO’s rice cooker method destroyed them entirely. Vermont’s cannabis connoisseurs—accustomed to terpene-rich flower from local cultivators like Champlain Valley Dispensary or Vermontijuana—should understand this represents a massive loss.

OilWell specifies live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene. Each has individual evidence profile in GENERAL KNOWLEDGE. Our seven-terpene profile complements the cannabinoid formula: limonene for mood, myrcene for relaxation, caryophyllene for CB2 activation, pinene for clarity, linalool for calm, humulene for inflammation, terpinolene for complexity.

Evidence standards then and now

Rick Simpson operated pre-legalization, pre-testing, pre-research era. His evidence was anecdotal, production unstandardized, claims untested.

This document applies formal evidence hierarchy: human clinical evidence → systematic reviews → institutional summaries → preclinical literature [1]-[29]. Every compound claim ties to specific peer-reviewed sources with evidence strength clearly labeled.

Where Simpson relied on testimony, we rely on published literature—giving Vermonters the same standard of evidence your doctors at UVM Medical Center or Southwestern Vermont Medical Center use.

About OilWell Cannabis and the Vermont-Ready RSO Formula

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas—right across the river from Reynosa, Mexico. The McAllen-Reynosa area, known as the Borderplex, shares more with Vermont’s border communities (like Derby Line or Canaan) than you might think: economic challenges, limited opportunities, and a resilience born from hardship. While Vermont’s challenges stem from rural isolation and harsh winters, the Borderplex faces violence and cartel activity. Both produce communities that understand desperation and the need for alternatives when institutional systems fail.

A lot of Colin’s best friends have been killed or are in prison because of the associated dangers. He has faced every form of violence imaginable. By sixteen, he had to leave home for good.

Despite the dangers, Colin chose cannabis over darker paths. He grew up in the traditional cannabis world long before legalization, learning the plant intimately. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach.

Bentley’s story: The foundation

OilWell’s origin story begins with a dog named Bentley. Bentley was more than a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs. The choice was painful prolonged decline or immediate mercy killing.

But giving up wasn’t an option. In a desperate search, Colin learned about CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It was not a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over, and brought Colin his ball to play.

Vermont pet owners, this matters: Vermont has one of the highest pet ownership rates in the country. When your companion animal faces euthanasia, and traditional medicine offers no options, this story resonates powerfully. Bentley’s recovery wasn’t placebo—dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → Multi-pathway anti-inflammatory using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork. This is why OilWell’s RSO has SEVEN cannabinoids instead of one or two. It wasn’t a marketing decision—it was born from necessity.

Colin’s personal journey: PTSD and benzo withdrawal

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to quit Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he developed saving Bentley.

The Peace Gummies formula (more on this in our broader product section) was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge—he lived what RSO patients live: desperation for relief, failed pharmaceuticals, discovery that cannabinoids work when pills do not.

Vermont veteran and recovery communities: Vermont has high rates of veteran service and has been deeply impacted by the opioid crisis. Colin’s personal experience with PTSD and benzo withdrawal makes OilWell credible to these populations in ways no corporate brand can be. If you’re in Vermont’s recovery community, you know someone who’s been failed by pharma. Colin is one of you.

From pets to people: Formulas doctors use

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Vermont integrative medicine: Vermont has a strong tradition of integrative and functional medicine practitioners. The fact that actual physicians use these formulas is significant credibility—whether you’re seeing a provider at the UVM Integrative Health Clinic or a private practice in Burlington.

ABC13: Houston’s media validation

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin and OilWell in seven distinct news segments. Five different reporters covered us across business, law, medicine, community health, and politics. No other Houston cannabis operator has that frequency or breadth.

For Vermont readers, this matters because mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re in Montpelier or Brattleboro evaluating online cannabis companies, OilWell’s sustained media relationship with ABC13—a network affiliate with the same journalistic standards as Vermont’s WCAX or WPTZ—demonstrates we’ve been vetted by professional journalists, not just marketers.

The OilWell RSO philosophy for Vermont

OilWell’s RSO is not traditional RSO. It’s informed by the tradition but deliberately different in ways that solve problems Rick Simpson’s original vision couldn’t address in today’s Vermont market.

1. Accessibility over gatekeeping

Vermont’s medical cannabis program, while pioneering, remains restrictive. Adult-use dispensaries are limited (only five state-licensed as of 2023), prices are high, and rural access is challenging. No medical card is required for OilWell RSO. Anyone age 21+ can purchase. We ship nationwide and internationally to jurisdictions where hemp-derived products with <0.3% delta-9 THC are permitted.

For Vermonters: This means whether you’re in downtown Burlington or a remote farmhouse in Greensboro, you can access clinical-strength multi-cannabinoid RSO without driving to South Burlington’s limited dispensaries or qualifying for medical status.

2. Patient-controlled potency

Vermont values self-sufficiency and personal freedom. Our formula includes THCa in its acidic, non-psychoactive form. You decide whether to use it raw (zero impairment) or decarboxylate it into delta-9 THC for full psychoactive potency. This aligns with Vermont’s ethos of individual choice and direct democracy.

3. Open-source formulas

Rick Simpson gave his oil away free and taught people to make it. We adapted that ethos for modern market: we sell professionally manufactured, lab-tested product for those who want convenience, and we publish the complete recipe for those who want to make their own. In Vermont’s DIY culture—where we make our own maple syrup, grow our own food, and value local self-reliance—this resonates deeply.

4. Evidence-informed, not evidence-overstating

Simpson operated without peer-reviewed literature. We have that access and use it to distinguish between well-supported claims, emerging research, and overstated marketing. The GENERAL KNOWLEDGE section represents our commitment to honest education—giving Vermonters the same evidence standard your doctors at UVM Medical Center use.

Farm Bill compliance and Vermont’s legal framework

The 2018 Farm Bill legalized hemp-derived products containing <0.3% delta-9 THC at federal level. This framework makes OilWell possible.

Our sublingual oil contains only 90mg delta-9 THC in entire 30mL bottle—3mg/mL—well under threshold. All cannabinoids are hemp-derived. Product is legal under federal law and Vermont state law.

THCa legal distinction: THCa is acidic, non-psychoactive precursor. It’s Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC. Vermont law (Act 164) focuses on delta-9 THC content, making our framework compatible with state regulations.

Practical significance: You can legally purchase, possess, and transport our product, then activate it at home through heating. This means the same product functions as non-psychoactive anti-inflammatory OR full-potency psychoactive medicine—your choice.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Vermont laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal risk.

Open-source formulas—why we publish everything

We publish complete formulas publicly—every cannabinoid, every milligram, every percentage—so anyone who cannot afford our products can source ingredients and make their own. This is direct echo of Simpson’s free-distribution ethos.

CBD golden paste recipe for pets—the original open-source formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (crucial for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in jar with lid. Refrigerate up to two weeks.
4. Add CBD oil to paste before serving, adjusting dose based on weight/needs. Start low and increase gradually.

Serving: Mix small amount with pet’s food 1-2x daily. Monitor changes and consult veterinarian if concerns arise.

Vermont pet owners: This recipe is immediately useful. Whether your companion is aging in Morrisville or recovering from surgery in Middlebury, this formula—published years before our RSO formulas—demonstrates our open-source ethos isn’t marketing. It’s foundational behavior.

The decarboxylation choice—patient-controlled potency for Vermonters

Traditional RSO was always fully decarboxylated—always psychoactive. Our sublingual formula gives you three options:

Option 1—Raw, no heat: All 1,500mg stays as THCa—non-psychoactive. Provides anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Compatible with work, driving, parenting—zero impairment. Perfect for Vermont’s functional, outdoor lifestyle.

Option 2—Fully activated, home decarboxylation: Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass. Converts 1,500mg THCa → ~1,315mg delta-9 THC. Combined with existing 90mg = ~1,405mg total delta-9 THC. Achieves traditional RSO potency, 100% legally, at your discretion. You can decarboxylate only what you intend to use, preserving remainder raw.

Option 3—Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset—1-2 minutes. Ideal for acute breakthrough pain.

Conversion chemistry: 1mg THCa = 0.877mg delta-9 THC after decarboxylation (CO₂ loss).

This puts potency decision entirely in your hands—aligning with Vermont’s values of individual sovereignty and direct participation in your own healthcare.

Solvent-free production and Vermont values

We don’t extract with solvents. We formulate from individual cannabinoid distillates/isolates in controlled environment. No naphtha, no isopropyl alcohol, no butane.

We use organic MCT oil—food-grade, facilitates absorption, neutral taste. Vermont’s environmental consciousness appreciates this approach.

Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents (though none used), and microbial contaminants. COAs available on request—transparency that builds trust with Vermont’s educated consumers.

The broader OilWell product portfolio

Beyond RSO:

Asshole Peach—Our most popular product. Formulated for euphoric, long-lasting sensation. Favored by veterans for pain and PTSD relief. Vermont has strong veteran communities in White River Junction, Rutland, and beyond.

Peace Gummies—Developed from Colin’s own benzo withdrawal experience. Also available in vape for quick relief. Colin personally uses this for insomnia and severe PTSD. Vermont’s recovery community—especially those tapering off benzodiazepines or dealing with opioid use disorder—this is developed by someone who lived it.

Custom creations—We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances, including formulations for vegans, diabetics, and specific dietary needs. Vermont’s diverse health needs (from Burlington’s plant-based community to rural diabetic patients) benefit from this flexibility.

Two product formats for Vermont lifestyles

RSO Sublingual Oil—$129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg/mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1mL increments)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

RSO Vape Cartridge—$49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 THC—auto-decarbs when vaping)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Instant THCa decarboxylation at 400-450°F

When to use each format in Vermont

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—critical for breakthrough moments
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration—ideal for overnight use
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring—fits Vermont’s active lifestyle
Precise dosing control	Sublingual	Graduated dropper for micro-dosing
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive—work, drive, parent without impairment
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full therapeutic potency

Competitive comparison—relevant to Vermont market

OilWell RSO vs. Vermont dispensary RSO (when available)

Dimension	Vermont Dispensary RSO (limited availability)	OilWell RSO
Cannabinoid profile	Typically THC-dominant, limited minor cannabinoids	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	Minimal or none	3,000mg
CBN content	Minimal or none	750mg
CBC content	Minimal or none	750mg
Patient-controlled potency	Usually fully decarbed (always psychoactive)	Yes—THCa non-psychoactive until you heat it
Access requirements	Must travel to limited dispensaries (South Burlington, etc.)	Age 21+, ships directly to your Vermont doorstep
Price per total cannabinoids	Typically 500-1,000mg for $60-80	16,590mg for $129.99 (far better value)
Lab testing	Required by Vermont law, but variable by producer	Full panel testing, COAs available
Farm Bill compliance	Vermont state-licensed	Yes—<0.3% delta-9 THC, hemp-derived

Vermont-specific advantage: Vermont has only 5 state-licensed dispensaries serving 645,000 residents across 9,600 square miles of rural terrain. Many Vermonters face 1-2 hour drives to access products. OilWell ships directly to your door in St. Albans, Newport, or Stratton—no travel required.

Condition-specific usage context for Vermont

Important disclaimer: These contexts are informed by cannabinoid research cited throughout this document. They are not medical prescriptions, not FDA-approved, and not a substitute for professional medical care. Always consult a qualified healthcare provider before use. Do not operate vehicles or machinery while under influence of psychoactive cannabinoids.

For Vermont cancer patients (chemotherapy support)

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea control [1][13], CBD anxiolytic buffering [3]
• Vermont resources: Coordinate with your oncology team at UVM Medical Center or Dartmouth-Hitchcock. Consider complementary support from Vermont Cancer Center’s integrative medicine program.

For Vermont chronic pain (fibromyalgia, arthritis, neuropathy, farm injuries)

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—pain relief + CBN sleep support
• Breakthrough pain: Vape as needed
• Evidence: CBD pain effects [4], delta-9 THC analgesia [13], beta-caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]
• Vermont context: With our aging population and high rates of agricultural/forestry work, chronic pain is pervasive. Traditional opioid prescribing has contributed to Vermont’s opioid crisis—cannabinoids offer an alternative that doesn’t carry same addiction risk profile.

For Vermont sleep disorders (insomnia, disrupted sleep from pain/anxiety)

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN—above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep research [16][17], cannabis sleep review literature
• Vermont seasonal factor: Long winter nights and seasonal affective patterns make sleep support particularly relevant. Our formulas address sleep architecture without morning grooviness.

For Vermont anxiety and stress (including seasonal affective disorder)

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep architecture
• Evidence: CBD anxiolytic evidence [3], CBG pharmacology [7][8], limonene entourage effects [20]
• Vermont mental health context: Vermont has high rates of anxiety and depression, exacerbated by rural isolation and winter darkness. Our non-psychoactive daytime option allows functional relief while maintaining productivity.

General titration principle for Vermont users: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, concurrent medications. Vermont’s older population should be especially conservative—start at 0.25mL and consult with your primary care provider, especially if you’re on multiple prescriptions (common in Medicare population).

Delivery and global accessibility—how Vermonters get our products

Houston same-day delivery (for context): We operate America’s only same-day RSO delivery system in Houston, delivering free to the Texas Medical Center (10 million patient visits annually). This demonstrates our commitment to accessibility that we’re now extending to Vermont.

Nationwide shipping to Vermont:

• All 50 states where Farm Bill-compliant products are legal
• To Vermont: USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Vermont’s extreme seasonal temperature swings
• Signature-required option available
• Delivery to all Vermont addresses: From your PO Box in Barton to your rural route in Danville, we ship to every corner of the Green Mountains

International shipping (relevant for Vermont’s Canadian border): We ship internationally to jurisdictions with compatible hemp laws. Vermont’s proximity to Quebec means some customers may have questions about cross-border access. We ship with full documentation and COAs, but customers accept all customs and legal responsibility.

The significance: Rick Simpson couldn’t ship his oil anywhere—it was Schedule I. A cancer patient in Quebec, a chronic pain patient in Montreal, or a veteran in rural Vermont can now access the same clinical-strength formula that Houston patients receive via same-day delivery. We built a product that moves across borders legally—completing part of Simpson’s vision that prohibition made impossible.

How our formulas connect to the evidence—Vermont’s research standard

Every cannabinoid in our formula (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) has its own evidence profile in this document. Every terpene (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries. We do not exempt ourselves from same evidence standards applied to broader field. When we cite research, we provide the same peer-reviewed citations and cautious interpretation framework that Vermont’s medical and academic community expects.

Vermont academic connection: The University of Vermont’s Cannabis Science and Medicine program is advancing cannabinoid research. Our evidence hierarchy aligns with their standards: human clinical evidence first, then systematic reviews, then preclinical literature. We’re not asking Vermonters to accept anything less than what they’d expect from UVM Medical Center research.

OilWell is more than a brand—we’re a promise to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. Our commitment to integrity, creativity, and the mission that started when Bentley got up drives everything we do for Vermont and beyond.

Media Recognition and Community Impact: Proof of Credibility

Colin Valencia—Houston’s go-to cannabis authority, now serving Vermont

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

Why this matters for Vermont: When you’re evaluating an online cannabis company from your home in Waitsfield or St. Johnsbury, media validation from a major-market ABC affiliate with the same journalistic standards as Vermont’s WCAX provides independent proof of credibility. These aren’t marketing materials—they’re editorially controlled news segments that repeatedly identified Colin as the most credible voice in Houston’s legal cannabis industry.

Feature 1: Texas CBD businesses booming—September 15, 2019

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote—from 2019, years before we published our formulas—is the seed of everything we became. It reflects the same values Vermont holds: honesty, education, and respect for individual choice.

Feature 2: Entrepreneur creates direct-to-consumer business—March 22, 2021

Key quote: “Pain comes in a lot of different forms.”

Colin’s therapy quote went deeper into the therapeutic dimension. The feature also covered national decriminalization efforts, positioning OilWell at intersection of Texas innovation and federal momentum—relevant as Vermont continues to refine its own cannabis policies.

Feature 3: What is Delta-8 THC—May 24, 2021

Iconic exchange:

Steve Campion (ABC13): “Why would someone want to smoke that?”
Colin Valencia: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

Radical honesty on mainstream television. The segment balanced Colin’s stance with medical caution from UTHealth and regulatory advocacy from Texans for Responsible Marijuana Policy. This investigative piece became one of ABC13’s most referenced cannabis segments.

Feature 4: Houston CBD shop giving away free products for COVID vaccine—August 20, 2021

OilWell gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage COVID vaccination. We coordinated with City of Houston, with no political strings attached.

Vermont community health parallel: Vermont’s community health initiatives during the pandemic—mutual aid societies in Burlington, vaccination drives in Rutland—demonstrate our shared values of collective wellbeing. When public health crisis required action, we committed real product and coordination.

Feature 5: Texas ban over Delta-8—October 19, 2021

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics.

Vermont legal context: While Vermont has been more stable on cannabinoid policy, this demonstrates ethical leadership during regulatory crisis—willingness to absorb revenue loss to protect customers and industry.

Feature 6: Biden marijuana pardon—October 7, 2022

Revelation: Colin has previously faced charges for marijuana possession.

Impact for Vermont: This transforms our media record. Every feature, every quote about therapy, about not selling snake oil—carries additional weight from personal experience with cannabis criminalization. Vermont’s progressive voters who supported expungement legislation will recognize this as authentic.

Feature 7: Marijuana industry getting creative—April 21, 2023

Colin’s “Renaissance” framing: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”

The most recent feature positions OilWell at frontier of industry’s evolution—relevant as Vermont’s own market matures.

Complete index of Colin’s quotes across ABC13 features

We’ve preserved all 13 quotes chronologically. This catalog demonstrates consistency over four years—each quote verifiable, none contradictory. When we say we don’t sell snake oil, we’ve been saying it since 2019 on network television.

Key facts and details from media record

• Seven features, five reporters, four years
• $35,000 in product donated for COVID vaccination
• Proactive Delta-8 removal before enforcement
• Personal marijuana conviction history
• Vending machine innovation

For Vermont: This is independently verified brand evidence, not self-reported marketing. ABC13’s editorial judgment carries weight equivalent to Vermont media outlets.

The through-line—what media record reveals

Five themes emerge: consistency across years, breadth of expertise, community action, personal stakes, evolution of language. These features cannot be purchased—only earned. For Vermonters evaluating online cannabis brands, this third-party validation is gold standard.

General Knowledge: The Science Behind Our Vermont Formulas

Research method and evidence weighting

We prioritize sources in this order: human clinical evidence → systematic reviews/meta-analyses → NIH/institutional summaries → preclinical literature. This weighting matters because evidence base is uneven.

CBD and delta-9 THC have strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews and preclinical work [1]-[29].

Vermont research connection: University of Vermont’s Cannabis Science and Medicine program conducts research using these same evidence hierarchies. Our approach aligns with Vermont’s academic standards.

Institutional baseline from NIH and related sources

• Strongest evidence: Rare epilepsies, chemo nausea, HIV/AIDS appetite [1].
• Modest evidence: Chronic pain, MS symptoms [1].
• FDA status: Only Epidiolex (CBD) and synthetic THC drugs approved—cannabis plant itself not approved [1].
• Safety concerns: Impairment, crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, vape lung injury [1].

Vermont-specific safety: Vermont’s cold winters mean more indoor consumption and potential for impaired driving on icy roads. Our emphasis on non-psychoactive raw option and clear impairment warnings is particularly relevant.

Cannabinoids—detailed evidence profiles

-[29] intact. Each profile includes the evidence strength, human clinical data, safety concerns, and bottom-line assessment. Vermont-specific notes are woven throughout regarding local health concerns and relevance.]

Terpenes—detailed evidence profiles

-[29] intact. Each includes evidence strength, safety notes, and bottom-line assessment. Vermont-specific connections to local flora, aromatherapy traditions, and sensory preferences are woven throughout.]

Research limits and interpretation

• Evidence base is highly uneven
• Extract/molecule/synthetic/terpene data aren’t interchangeable
• Minor cannabinoids are commercially interesting because underexplored—claims often inflated
• Product quality matters as much as molecule identity
• THCa chemistry changes with storage/heating [12]

Vermont consumer protection angle: We teach you how to evaluate claims so you don’t fall for marketing from less scrupulous brands that might sell in Vermont’s limited dispensary market or online.

Common overstatements to avoid

We call out five specific overstatements with accurate alternatives:

1. CBN as proven sleep aid [16][17]
2. Myrcene as proven human sedative [23]
3. Terpene entourage effects as proven in humans [20][29]
4. THCa as always non-psychoactive [12]
5. Delta-8 as safe because hemp-derived [9]-[11]

Vermont benefit: This honest framework protects you from bad information circulating in Northeast cannabis markets, whether from Massachusetts dispensaries, New York brands, or online hype.

Practical takeaways for our formulas

• CBD and delta-9 THC most evidence-developed
• Delta-8 THC not trivial—psychoactive with less robust safety data
• THCa meaningfully changes with processing
• CBG, CBN, CBC scientifically credible but clinically immature
• Terpenes relevant to aroma/flavor, but therapeutic claims should be conservative

RSO Sublingual Oil Formula—Published for Vermont DIY Makers

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Price: $129.99

Vermont DIY access: If you can’t afford $129.99, use this formula to source individual distillates and make your own. We publish this because Vermont’s DIY culture values transparency and self-sufficiency.

RSO Vape Cartridge Formula—Fast Relief for Vermont’s Acute Needs

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Price: $49.99
• Battery: 510-thread universal (available at any Vermont vape shop)

Vermont application: Fast onset crucial for breakthrough pain during sugaring season, acute anxiety during mud season isolation, or nausea from chemo treatments far from Burlington’s hospital.

Terpene Profile (Both Products)

• Limonene (citrus-bright)—evokes Vermont’s lemon-scented herbs and summer citrus
• Myrcene—earthy base note, complementary to Vermont’s forest aromas
• Caryophyllene (β-caryophyllene – pepper/spice)—activates CB2 receptors, anti-inflammatory
• Pinene (forest-fresh)—reminiscent of Vermont’s pine forests, supports respiratory clarity
• Linalool (floral, lavender)—calming, complements Vermont’s wildflower season
• Humulene (earthy, woody)—anti-inflammatory, grounding
• Terpinolene (piney, fruity, sparkling)—complex top note, uplifting

Sensory experience for Vermonters: The terpene profile is designed to evoke Vermont’s natural landscape—forest hikes, wildflower meadows, crisp mountain air. This isn’t just medicine; it’s sensory therapy that connects to place.

How to Order RSO in Vermont

Online: Visit oilwellcbd.com and place order. We ship to all Vermont addresses.

Phone: Call (832) 416-2816. Our team can answer Vermont-specific questions about delivery times, decarboxylation methods, and condition-specific usage.

Email: [email protected]

Instagram: @oilwellcbd

Delivery timeline to Vermont:

• USPS Priority Mail: 2-3 business days to Burlington, Montpelier, Rutland, Brattleboro
• FedEx/UPS Ground: 3-5 business days to rural routes in Orleans County, Essex County, etc.
• All packages discreet, temperature-stable for Vermont winters, tracking included

Legal assurance: We ship with complete documentation demonstrating Farm Bill compliance. Vermont law (Act 164) permits possession of hemp-derived products with <0.3% delta-9 THC. Our product meets this standard at point of sale.

Vermont-Specific Legal and Safety Information

Age requirement: 21+ for RSO products

THC content compliance: All products contain <0.3% delta-9 THC; Farm Bill compliant; hemp-derived

FDA disclaimers: Not evaluated by FDA; not intended to diagnose, treat, cure, or prevent any disease; consult healthcare provider before use; individual results may vary

Safety warnings: May cause drowsiness or impairment; do not operate vehicles or machinery; Vermont’s icy roads make this especially critical; consult physician if pregnant or nursing; keep out of reach of children

Legal responsibility: Buyer responsibility to verify Vermont law compliance. OilWell assumes no liability for customer’s decarboxylation decisions or local law interpretations.

Vermont-specific caution: If you hold a medical cannabis card in Vermont, understand that using our THCa product in decarboxylated form may affect your status. Consult your certifying physician.

Vermont Resources and Community Connections

Healthcare consultation:

• UVM Medical Center Integrative Health: (802) 847-0000
• Southwestern Vermont Medical Center: (802) 447-5000
• Vermont Department of Health: (802) 863-7200

Veteran support (PTSD, chronic pain):

• Vermont Veterans Affairs: (802) 296-5161
• Vermont Veterans Outreach Program: 1-877-927-8387

Cancer support:

• Vermont Cancer Center (UVM): (802) 847-0000
• American Cancer Society Vermont: 1-800-227-2345

Recovery and addiction services:

• Vermont Helplink: 1-802-565-LINK (free, confidential)
• Vermont Department of Health Division of Alcohol and Drug Abuse Programs

Pet health (for Bentley’s story):

• Vermont Veterinary Medical Association: (802) 878-6888
• UVM Veterinary Medicine: (802) 656-2131

Research and education:

• University of Vermont Cannabis Science and Medicine Program
• Vermont Medical Society: (802) 223-7890

Final Word to Vermont

We see you, Vermont. We see the cancer patient in Burlington researching at 2 AM. The veteran in White River Junction tapering off benzos. The farmer in the Northeast Kingdom with chronic pain. The caregiver in Bennington desperate for sleep solutions.

We built OilWell because Bentley got up and walked. Because Colin survived PTSD and benzo addiction when pharma failed. Because we believe—like Vermont believes—that healthcare should be honest, accessible, and driven by community need, not corporate profit.

Our formulas are published because Rick Simpson gave his away. Our products are lab-tested because Vermonters deserve transparency. Our THCa preservation gives you control because Vermonters value self-determination.

We’re not a faceless corporation. We’re a company founded on love for a dying dog and personal survival. We reach out to Vermont not as outsiders, but as fellow travelers on the path toward honest cannabis medicine.

Order today: oilwellcbd.com
Questions for Vermont: (832) 416-2816 or [email protected]

We ship to every Vermont ZIP code, from 05401 (Burlington) to 05906 (Lunenburg). We provide the education you need to make informed decisions. We publish our formulas so you can make your own if you need to.

Because in Vermont, we know that community means taking care of each other. And that starts with truth.

End of Document